- Home
- BKYI vs PFSA Comparison
BKYI vs PFSA Comparison
Compare BKYI & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKYI | PFSA |
|---|---|---|
| Founded | 1993 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 8.9M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | BKYI | PFSA |
|---|---|---|
| Price | $0.62 | $2.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 9.2M | 232.3K |
| Earning Date | 03-26-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $6,316,050.00 | N/A |
| Revenue This Year | $7.45 | N/A |
| Revenue Next Year | $23.29 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 122.22 |
| 52 Week Low | $0.51 | $2.80 |
| 52 Week High | $1.97 | $957.00 |
Technical Indicators
Market Signals| Indicator | BKYI | PFSA |
|---|---|---|
| Relative Strength Index (RSI) | 46.00 | 81.22 |
| Support Level | $0.65 | $0.05 |
| Resistance Level | $0.71 | $4.22 |
| Average True Range (ATR) | 0.08 | 0.18 |
| MACD | -0.01 | 0.32 |
| Stochastic Oscillator | 22.48 | 63.61 |
Price Performance
Historical ComparisonAbout BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About PFSA Profusa Inc.
Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.